Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis
about
Modulation of the CD95-induced apoptosis: the role of CD95 N-glycosylationInactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndromeGenetics of neoplasia--impact of ecogenetics on oncogenesis. A review.Spontaneous cytotoxicity of rheumatoid and normal peripheral blood mononuclear cells against 4 human lymphoblastoid cell lines.Spontaneous lymphocyte-mediated (NK cell) cytotoxicity in systemic sclerosis: a comparison with antibody-dependent lymphocyte (K cell) cytotoxicity.Restricted expression of EBV latent genes and T-lymphocyte-detected membrane antigen in Burkitt's lymphoma cells.Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter.T-cell memory: lessons from Epstein-Barr virus infection in manRelationship of in vitro immune responses to Epstein-Barr herpesvirus and severity of infectious mononucleosis.In vitro cytotoxicity against Marek's disease lymphoblastoid cell lines after enzymatic removal of Marek's disease tumor-associated surface antigen.Infectious mononucleosis and mononucleosis syndromes.Development of antibodies reactive in antibody-dependent cellular cytotoxicity in infectious mononucleosis.Pathogenesis of Marek's disease; effect of immunization with inactivated viral and tumor-associated antigensThe immunology of Epstein-Barr virus infectionInterleukin-10 inhibits apoptotic cell death in infectious mononucleosis T cellsExpansion of a CD28-intermediate subset among CD8 T cells in patients with infectious mononucleosisSuppressor T cell clones from patients with acute Epstein-Barr virus-induced infectious mononucleosisEpstein-Barr-virus-carrying lymphoma in a patient with ataxia-telangiectasia.Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: contrasting consequences of host versus tumor evolution.Comparison between growth characteristics of an Epstein--Barr virus (EBV)-genome-negative lymphoma line and its EBV-converted subline in vitro.Epstein-Barr virus RNA. VI. Viral RNA in restringently and abortively infected Raji cells.Epstein-Barr virus RNA VII: size and direction of transcription of virus-specified cytoplasmic RNAs in a transformed cell line.Cytotoxic lymphocytes in infectious mononucleosis.Epstein-Barr virus (EBV) infects T lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan.Marek's disease as a model for the Landry--Guillain--Barré syndrome: latent viral infection in nonneuronal cells accompanied by specific immune responses to peripheral nerve and myelinA quantitative ultrastructural study of peripheral blood lymphocytes containing parallel tubular arrays in Epstein-Barr virus and cytomegalovirus mononucleosis.In vitro immune responses to PPD, extracts from Raji cells and nasopharyngeal carcinoma biopsies in NPC leucocytesDetection of an Epstein-Barr virus-associated membrane antigen in Epstein-Barr virus-transformed nonproducer cells by leukocyte migration inhibition and blocking antibodyMembrane antigen on Epstein--Barr virus-infected human B cells recognized by a monoclonal antibody.Repeat array in Epstein-Barr virus DNA is related to cell DNA sequences interspersed on human chromosomesSuppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes.Absence of allogeneic restriction in human T-cell-mediated cytotoxicity to Epstein-Barr virus-infected target cells. Demonstration of an HLA-linked control at the effector levelInhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen.Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memoryPathogenesis of an infectious mononucleosis-like disease induced by a murine gamma-herpesvirus: role for a viral superantigen?Target selectivity of interferon-induced human killer lymphocytes related to their Fc receptor expression.HLA antigen-related restriction of T lymphocyte cytotoxicity to Epstein-Barr virus.Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivityPapain solubilization of the Epstein-Barr virus-induced membrane antigen.Epstein-Barr virus and human diseases: recent advances in diagnosis
P2860
Q24305009-9CAF513D-31C5-43D5-A867-7ECE050A2D11Q24653357-C61CC39E-926C-42E2-8E2B-9413ADB57783Q30500345-BF57380A-DB6A-40B9-85CB-3A5C1C1B29A9Q33552769-E764ED91-9210-4795-BB6B-49A2884AC5F2Q33553776-FA22892E-6947-440E-B23A-8CAFA4EED394Q33880494-B8E7C533-AE63-432E-BD5F-78AE91CEF850Q33880983-43B0B041-4C24-407D-8C2D-121B988D64BDQ33905235-2E61CA0F-7102-43F2-9598-3ED5EB8288DDQ33907657-3F56C736-3620-4A6F-BC38-D99F2F09AA65Q33917689-5BC3356A-FD63-455D-8AAF-7D4039DC1FD5Q34050950-3DECF116-B29F-481C-9729-9CD7A9A02134Q34081744-943880C6-023E-4E96-8BB2-2B22B91C4E6DQ34097285-61165038-7C17-454C-813E-12C7909B7579Q34225567-28D1460E-0B72-4DC6-AB62-89FA3D959FFEQ34235308-5BBDFFE9-8776-4848-8E91-A001D3FA963BQ34341657-67C74FAB-3AF9-44BF-9753-F4BF0463EB30Q34553140-624849CD-C0A6-4158-9E03-5C451BA92739Q34777403-C385768E-A560-4AC0-9D06-D88EC11CD574Q35028158-0F4D505A-B004-4D5E-A710-8167384599AFQ35088713-37103C7C-0DA5-43DF-9D9E-10260C332546Q35237835-C146E71A-E10A-49E8-ACAE-90DBF6DB4388Q35335767-6025A90B-03BF-4750-990D-15C3799145DEQ35814533-77F02248-79E9-43CE-825E-E09BE929C19DQ35834158-C65651BF-EF7D-4B52-B5CC-C43726A6EB8BQ35864140-66B064A5-4D6D-43F7-A775-D332E50B10DEQ35884890-B85CD81C-7970-44F6-967E-18F06D06EE98Q36069431-4174E537-23ED-494C-A349-B5A71FD077A9Q36265053-B4EA8818-8BC3-4456-B1BC-4DBC017ACDB8Q36292549-92BABF32-AFCA-444C-B378-6CA6177405A3Q36314098-1B973C5A-1F68-4C91-AB71-16B22A7FDB79Q36335723-6AD4137F-2469-40C6-81B5-17729AD5314CQ36343066-568B4971-F783-4435-BF3B-EC9B0D887F14Q36349979-AE9F5C86-8AD6-474F-AFD2-CACAD8A53939Q36367550-714F4AB4-4379-4817-8C71-52EF0D65E24CQ36377221-E4588D11-6F73-4203-8A45-662870CAF7CBQ36394762-3F5AD725-01AD-48CC-959B-9F4581A3C4E8Q36398950-2C5428A8-E550-4C95-ADA7-E19D3FF40FC3Q36406027-13F7DC24-3BFB-46D2-8A1B-50C846B67BBFQ36525389-253D2E84-43A7-45AE-BCFF-18A24F5D0CC9Q36633160-0521D402-5514-40DB-BD0E-059974244FFB
P2860
Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis
description
1975 nî lūn-bûn
@nan
1975 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1975 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
name
Cytotoxic effector cells speci ...... with infectious mononucleosis
@ast
Cytotoxic effector cells speci ...... with infectious mononucleosis
@en
type
label
Cytotoxic effector cells speci ...... with infectious mononucleosis
@ast
Cytotoxic effector cells speci ...... with infectious mononucleosis
@en
prefLabel
Cytotoxic effector cells speci ...... with infectious mononucleosis
@ast
Cytotoxic effector cells speci ...... with infectious mononucleosis
@en
P2860
P356
P1476
Cytotoxic effector cells speci ...... with infectious mononucleosis
@en
P2093
P2860
P304
P356
10.1073/PNAS.72.4.1622
P407
P577
1975-04-01T00:00:00Z